• UPM expects second-half 2026 comparable EBIT from continuing operations of €375 million–€575 million, excluding discontinued plywood operations.
• Third-quarter comparable EBIT from continuing operations fell 8% to €131 million as customer destocking reduced deliveries and variable costs increased.
• Operating cash flow rose to €420 million from €218 million a year earlier, supported by improved working capital efficiency.
• The European Commission reiterated serious concerns about the planned Sappi graphic paper joint venture; discussions cover specific remedies, excluding divestments.
• Leuna’s integrated biochemicals production is expected to start in second-quarter 2027, with nominal capacity targeted for early 2028.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. UPM-Kymmene Oyj published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.